Haemonetics reports Q2 FY2024 results; specific figures not included in filed document

HAEMONETICS CORP

2024-Q2 EPS reported $1.28 revenue$629,515,000

Earnings release dated November 2, 2023 for quarter and first half ended September 30, 2023.
Press release was furnished as Exhibit 99.1 but its text was not provided in the filing.
No financial metrics, guidance changes, or segment data available for analysis.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HAEMONETICS CORP reported financial results for the second quarter ended September 30, 2023.

Period: the second quarter ended September 30, 2023
Result: reported results

Exact text from the filing

On November 2, 2023, Haemonetics Corporation issued a press release announcing financial results for the second quarter ended September 30, 2023 and first half of fiscal 2024.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-23-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.